England | Scotland | Wales | Northern Ireland | Ireland
Get the latest NHS information and advice about coronavirus (COVID-19)
Get tested for COVID-19
Find out about the main symptoms of coronavirus and what to do if you or your child has them.
Get a test to check if you have COVID-19, find out what testing involves and understand your test result.
Get your COVID-19 vaccination, read about the vaccines and find out what happens when you have your vaccine.
NHS COVID Pass
Find out how to get your COVID Pass to attend trial events in England or to travel abroad.
Self-isolation and treating symptoms
Advice about staying at home (self-isolation) and treatment for you and anyone you live with.
People at high risk
Advice for people at higher risk from COVID-19, including older people, people with health conditions and pregnant women.
Long-term effects (long COVID)
Find out about the long-term effects coronavirus can sometimes have and what help is available.
Advice about avoiding close contact with other people (social distancing), looking after your wellbeing and using the NHS and other services.
Using the NHS and other health services
Find out about changes to using health services, such as GPs and hospitals, because of COVID-19.
Take part in research
Find out about health research studies and how you may be able to take part.
Download the NHS COVID-19 test and trace app
Lanark Medical CentreGround Floor Surgery165 Lanark RoadLondon, W9 1NZTel: 0207 328 1128
Dear patients, please call the surgery prior to attending an appointment if you are using a pushchair, pram or wheelchair to ensure that the lift is in working order. THANK YOU FOR YOUR CO-OPERATION.
We run a wide range of clinics at our surgery which are all supervised by our practice nurses. These clinics are listed below as follows:
The musculoskeletal (MSK) service is a self-referral department for patients. You do not need to make an appointment with the GP to be referred. To make a routine appointment for Physiotherapy and Pain Management contact 0203 752 6060.
If you require any vaccinations relating to foreign travel you need to make an appointment with the practice nurse to discuss your travel arrangements. This will include which countries and areas within countries that you are visiting to determine what vaccinations are required.
There is further information about countries and vaccinations required on the links below:
It is important to make this initial appointment as early as possible - at least 6 weeks before you travel - as a second appointment will be required with the practice nurse to actually receive the vaccinations. These vaccines have to be ordered as they are not a stock vaccine. Your second appointment needs to be at least 2 weeks before you travel to allow the vaccines to work.
Some travel vaccines are ordered on a private prescription and these incur a charge over and above the normal prescription charge. This is because not all travel vaccinations are included in the services provided by the NHS.
Travel Health Questionnaire
To help us offer the appropriate advice, please fill out the online form before coming to see the nurse.
Travelling in Europe
If you are travelling to Europe the EU has published useful information for travellers on the European website.
Some services provided are not covered under our contract with the NHS and therefore attract charges. Examples include the following:
The fees charged are based on the British Medical Association (BMA) suggested scales and our reception staff will be happy to advise you about them along with appointment availability.
Seasonal flu is a highly infectious illness caused by a flu virus.
The virus infects your lungs and upper airways, causing a sudden high temperature and general aches and pains.
You could also lose your appetite, feel nauseous and have a dry cough. Symptoms can last for up to a week.
We offer ‘at risk’ groups the flu vaccine at a certain time each year to protect you against the flu virus.
You may be invited for a flu jab if you are:
For more information please visit the websites below:
COVID-19 VACCINATION - BENEFITS OUTWEIGH RISKS
COVID-19 vaccination - benefits outweigh risks
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA), European Medicines Agency (EMA) and the World Health Organization have all reiterated that the benefits of the Oxford/AstraZeneca vaccine in the prevention of COVID-19 far outweigh any possible risk of blood clots amongst those groups currently eligible to receive their first vaccination, as well as all of those due their 2nd dose. Offering further reassurance, the EMA said that these extremely isolated cases “should be listed as very rare side effects”.
In those aged 18-29, an alternative vaccine will be offered when the time is right for vaccinating this group, and GPs will ensure the appropriate vaccine is offered, and any questions are answered. The UK’s Joint Committee on Vaccination and Immunisation (JCVI) has stated that this change in course has been made - not because there is a high risk to the under 30s from this vaccine, but due to them having taken an approach of the utmost caution - which should provide great reassurance, and is quite normal in the rollout of a global vaccination program.
More information can be found here:
COVID-19 vaccination and blood clotting - GOV.UK (www.gov.uk)
Text copied on following pages.
COVID-19 vaccination and blood clotting
The UK vaccination programme has been very successful with more than 30 million people vaccinated and more than 6,000 lives already saved.
What is the concern?
Recently there have been reports of a very rare condition involving blood clots and unusual bleeding after vaccination. This is being carefully reviewed but the risk factors for this condition are not yet clear.
Although this condition remains extremely rare there appears to be a higher risk in people who have had the first dose of the AstraZeneca (AZ) vaccine. Around 4 people develop this condition for every million doses of AZ vaccine doses given.
This is seen slightly more often in younger people and tends to occur between 4 days and 2 weeks following vaccination. Benefits and risks of the vaccination
Risk from COVID-19
Benefit of vaccination
Risk of vaccination
Over 50 years of age or having underlying medical conditions
Low - catching infection, passing on infection
1 dose – more than 80% reduction: deaths, hospitalisation, intensive care
Uncommon - sore arm, feeling tired, headache, general aches, flu like symptoms
Moderate - Long COVID
2 doses – more than 95% reduction: deaths
Extremely rare - clotting problems
Very high - hospitalisation, intensive care admission, death
30 to 49 years of age
Low - hospitalisation, intensive care admission, death
1 dose – between 60% and 70% reduction: catching infection, passing on infection
Common - sore arm, feeling tired, headache, general aches, flu like symptoms
2 doses – more than 85% reduction: catching and passing on infection
High - catching mild infection, passing on infection
18 to 29 years of age
Very low - hospitalisation, intensive care admission, death
Very common - sore arm, feeling tired, headache, general aches, flu like symptoms
Very high - catching mild infection, passing on infection
This condition can also occur naturally, and clotting problems are a common complication of COVID-19 infection. An increased risk has not yet been seen after other COVID-19 vaccines but is being carefully monitored. What to look out for after vaccination
Although serious side effects are very rare, if you experience any of the following from around 4 days to 4 weeks after vaccination you should seek medical advice urgently:
What you should do next Over 50 years of age or with underlying medical conditions
All older adults (including health and social care workers over 50 years of age), care home residents, health and social care workers (includes unpaid carers and family members of those who are immunosuppressed) and adults with certain medical conditions were prioritised in the first phase of the programme because they were at high risk of the complications of COVID-19.
The Medicines and Healthcare products Regulatory Agency (MHRA) and the Joint Committee on Vaccination and Immunisation (JCVI) advises that you should still receive any of the available COVID-19 vaccines. The benefits of vaccination in protecting you against the serious consequences of COVID-19 outweigh any risk of this rare condition. You should also complete your course with the same vaccine you had for the first dose.
If your first dose was with AZ vaccine without suffering any serious side effects you should have the second dose on time as you may still be at high risk of the complications of COVID-19. Having the second dose will give you higher and longer lasting protection.
If you are a healthy person over 30 to 50 years of age
The MHRA and the JCVI advises that all adults in this age group (including health and social care workers) should still receive any of the available COVID-19 vaccines.
The benefits of vaccination in protecting you against the serious consequences of COVID-19 outweigh any risk of this rare condition. You should also complete your course with the same vaccine you had for the first dose.
The MHRA and the JCVI advises that all adults in this age group (including health and social care workers) should still receive any of the available COVID-19 vaccines. The benefits of vaccination in protecting you against the serious consequences of COVID-19 outweigh any risk of this rare condition. You should also complete your course with the same vaccine you had for the first dose.
Currently JCVI has advised that it is preferable for people under 30 to have a vaccine other than AZ. If you choose to have another COVID-19 vaccine you may have to wait to be protected. You may wish to go ahead with the AZ vaccination after you have considered all the risks and benefits for you. About the second dose
If you have already had a first dose of AZ vaccine without suffering any serious side effects you should complete the course. This includes people aged 18 to 29 years who are health and social care workers, unpaid carers and family members of those who are immunosuppressed. It is expected that the first dose of the vaccine will have given you some protection, particularly against severe disease.
Further information can be found at NHS.UK.
Enter all or part of your postcode in the box below and click one of the buttons
to find those services that are local to you.